Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
CNTY-101 for Lupus
Recruiting1 awardPhase 1
Chicago, Illinois
This trial is testing a new drug called CNTY-101 in people with autoimmune diseases like lupus. The study will determine the safety and effectiveness of different doses of the drug in patients who have
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service